The Board of Directors at their meeting held on 11.08.2025 has fixed 18th September 2025 as record date for the payment of dividend for the financial year ended 31.03.2025, which is subject to the approval of the shareholders at the 38th AGM of the Company convened to be held on 25.09.2025.

pdf

Bal Pharma Ltd.

11 Aug 2025

85.29

-0.35%

Result

Bal Pharma Ltd - 524824 - Unaudited Financial For The Quarter Ended 30.06.2025.

BSE India

Unaudited financial results ( Standalone and consolidated ) for the quarter ended 30.06.2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	66.59	82.96	75.18	-19.7%	-11.4%
Operating Profit Qtr	6.06	7.64	6.47	-20.7%	-6.3%
Net Profit Qtr	0.20	5.43	0.26	-96.3%	-23.1%
Earning Per Share Adjusted latest Qtr	0.13	3.41	0.16	-96.2%	-18.8%

* Consolidated data

Detailed Results

Bal Pharma Ltd.

11 Aug 2025

85.29

-0.35%

Board Meeting

Bal Pharma Ltd - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

Board of Directors of the Company has met today and inter alia transacted the following business, 1. Approved the unaudited financial results ( standalone and consolidated ) for the quarter ended 30.06.2025. 2. Convened 38th Annual General meeting of the company on 25th September 2025 at 11.30 am through AV means. 3. Decided to close the register of members from 19.09.2025 to 25.09.2025 ( both days inclusive ) 4. Approved the ESOP -2025 plan, subject to the approval of shareholders. 5. e-Voting dates from 22.09.2025 to 24.09.2025, for the ensuing Annual General Meeting.

pdf

Bal Pharma Ltd.

29 Jul 2025

85.29

-0.35%

Board Meeting

Bal Pharma Ltd - 524824 - Board Meeting Intimation for Inter Alia Take On Record And …

BSE India

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter ended 30.06.2025. 2.Convene 38th Annual General Meeting of the Company. 3.To Fix Book Closure dates. 4. Employee Stock Option Plan -2025 5.Merger of Lifezen healthcare Pvt Ltd (Subsidiary) with Bal Pharma Ltd (Holding Company)

pdf

Bal Pharma Ltd.

10 Jul 2025

85.29

-0.35%

Company Update

Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are submitting to the exchanges newspaper advertisements of the notice issued to the shareholders regarding transfer of their shares to IEPF account , whose dividend is outstanding to be claimed from the year 2017.18.

pdf